One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...

Statins help people manage high cholesterol levels, but many experts want to know if these drugs can also support brain ...

His geriatric doctor said "no" to prescribing medication to help slow down the disease. The doctor said his pulse rate is low ...

Biogen BIIB and Japan-based partner, Eisai, announced an update regarding the regulatory review of an application seeking the ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

Charles Piller, author of the new book Doctored, says the scientific community needs “to take a good hard look in the mirror.

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

The European medicines regulator said on Friday it will review safety information for Eisai and Biogen's Leqembi, nearly ...